In adults, renal cell carcinoma is the most common type of kidney cancer. A growing number of studies show that astaxanthin is emerging as a key player in cancer therapy. In this research article, scientists described the effects of astaxanthin on cancer as well as inflammation. These observations make astaxanthin an attractive therapeutic agent for developing new treatment protocols, and possibly for combining with other chemotherapeutics to overcome drug resistance and achieve better outcomes in cancer treatment.
Kidney cancer usually does not have signs or symptoms in its early stages. In time, signs and symptoms may develop, including:
- Blood in your urine, which may appear pink, red or cola colored
- Pain in your back or side that does not go away
- Loss of appetite
- Unexplained weight loss